?-blockers in pulmonary arterial hypertension: generation might matter

Malenfant Simon, Perros Frédéric

Source: Eur Respir J 2016; 47: 682-684

Journal Issue: February

Disease area: Pulmonary vascular diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Malenfant Simon, Perros Frédéric. ?-blockers in pulmonary arterial hypertension: generation might matter. Eur Respir J 2016; 47: 682-684

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Is there an obesity paradox in pulmonary arterial hypertension? Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017
Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed Source: Eur Respir J 2010; 36: 986-990 Year: 2010
When is pulmonary hypertension not pulmonary hypertension? Source: Eur Respir J 2001; 18: Suppl. 33, 522s Year: 2001
Single arterial occlusion to locate resistance in patients with pulmonary hypertension Source: Eur Respir J 2003; 21: 31-36 Year: 2003
CC6 Is it truly pulmonary arterial hypertension? Source: Milan 2017 - Educational material Year: 2017
Inflammation in pulmonary arterial hypertension: is it time to quell the fire? Source: Eur Respir J 2014; 43: 685-688 Year: 2014
The revolution of pulmonary arterial hypertension Source: Eur Respir Rev 2016; 25: 361-363 Year: 2016
Iron deficiency in pulmonary arterial hypertension: A matter of definition! Source: International Congress 2016 – Pulmonary hypertension: the clinic I Year: 2016
Does gender matter in pulmonary hypertension? Source: Virtual Congress 2020 – Don't blame your parents: causes of pulmonary hypertension in early life Year: 2020
Evaluation of pulmonary hypertension by right heart catheterisation: does timing matter? Source: Eur Respir J, 56 (3) 1901892; 10.1183/13993003.01892-2019 Year: 2020
Beyond arterial remodelling: pulmonary venous and cardiac involvement in patients with systemic sclerosis-associated pulmonary arterial hypertension Source: Eur Respir J 2010; 35: 6-8 Year: 2010
Goal-oriented therapy in paediatric pulmonary arterial hypertension: are we ready? Source: Eur Respir J 2014; 44: 1404-1407 Year: 2014
Challenging the concept of adding more drugs in pulmonary arterial hypertension Source: Eur Respir J, 50 (3) 1701527; 10.1183/13993003.01527-2017 Year: 2017
Impaired right ventricular diastolic function in systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension Source: Annual Congress 2008 - Pulmonary vascular medicine Year: 2008
Pulmonary hypertension at exercise in COPD: does it matter? Source: Eur Respir J 2013; 41: 1002-1004 Year: 2013
The future of treatment for pulmonary arterial hypertension Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease Year: 2018
The future of treatment for pulmonary arterial hypertension Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2014
The future of treatment for pulmonary arterial hypertension Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2017
The future of treatment for pulmonary arterial hypertension Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease Year: 2012